Dr. Ken Cunningham

Executive Director

Dr Ken Cunningham stepped down as Chief Executive Officer on 23 August 2010 and will remain as an Executive Director until 30 September 2010. He originally joined the Company as Chief Operating Officer in April 2006 and was appointed to the Board in May 2006. On 1 September 2008 he was appointed Chief Executive Officer . Previously, he was Chief Executive Officer of Arakis Ltd, Vice-President European Affairs at Alza Corporation and Vice-President Clinical Development at Sequus Inc. Prior to this he held a variety of clinical development and commercial strategy roles at GlaxoWellcome plc and Warner-Lambert earlier in his career. Dr Cunningham is a Non-Executive Director of Xention Ltd. He holds a medical degree from St Mary's, Imperial College, London University.

Board of Directors

Executive Management

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom